Updated:
Velan Capital
Velan Capital is a healthcare-focused investment firm founded in 2017 in New York, New York. The company specializes in investment services for the healthcare...
Velan Capital
Velan Capital is a healthcare-focused investment firm founded in 2017 in New York, New York. The company specializes in investment services for the healthcare sector. It has made one investment, in Tenax Therapeutics, as part of a PIPE - III on August 06, 2024.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, NY, United States
Frequently asked questions
What investment strategy does Velan Capital pursue?
Velan Capital executes a control buyout strategy focused on middle-market companies in North America. The firm targets businesses with defensible market positions where it can drive value through operational improvements and strategic repositioning. Typical deal types include founder transitions and corporate carve-outs.
Which sectors and geographies does Velan Capital focus on?
Velan concentrates on North American companies, with a particular interest in industrial, healthcare, and business services sectors. The firm's geographic scope is primarily domestic US markets, consistent with lower middle-market buyout funds that emphasize proximity to portfolio companies and local operating expertise.
How does Velan Capital typically structure its investments?
Velan pursues control equity investments, acquiring majority stakes in target companies. The firm positions itself to influence operating decisions directly rather than holding minority passive positions. Its capital base is expected to come from committed blind-pool funds raised from institutional limited partners.
What is Velan Capital's known track record or recent deal activity?
Specific portfolio companies and realized exits are not publicly disclosed through standard channels. Private equity firms of Velan's profile frequently hold companies that do not issue public securities or ratings, making deal-level reporting voluntary. Further details would require direct engagement with the firm.
Who runs investment decisions at Velan Capital?
The firm's lead partners and investment committee composition have not been publicly profiled as of mid-2026. Due diligence on Velan would require identifying the named individuals responsible for sourcing, execution, and portfolio management, which is standard for evaluating emerging or lower-profile private equity sponsors.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: